Literature DB >> 9712240

Increased colonic permeability in patients with ulcerative colitis: an in vitro study.

P Nejdfors1, Q Wang, M Ekelund, B R Weström, O Jansson, C L Lindström, B Karlsson, B Jeppsson.   

Abstract

BACKGROUND: Colonic permeability was studied in vitro in patients subjected to colectomy because of ulcerative colitis and in control patients undergoing colonic resections for cancer.
METHODS: The mucosal layer from fresh colonic segments was stripped and mounted in Ussing diffusion chambers containing modified Krebs buffer solution. The mucosa to serosa passage of the marker molecules 14C-mannitol and ovalbumin was measured for 120 min.
RESULTS: Marker passage was significantly increased in colitis patients compared with control patients, irrespective of age, sex, duration of disease, and treatment. Marker passage was further increased in patients with acute colitis. The increased colonic permeability may be explained by inflammation and the resultant loss of mucosal integrity. The increased permeability to ovalbumin implies that permeability to luminal macromolecules, such as bacterial products and other antigenic substances, might be increased in colitis.
CONCLUSIONS: The results suggest a derangement of the colonic barrier, as evidenced by an increased mucosal permeability in both chronic and acute colitis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9712240     DOI: 10.1080/00365529850171701

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  10 in total

1.  Carprofen-induced oxidative stress in mitochondria of the colonic mucosa of the dog.

Authors:  Lynne A Snow; Rebecca S McConnico; Timothy W Morgan; Erica Hartmann; Jacqueline R Davidson; Giselle Hosgood
Journal:  Can J Vet Res       Date:  2014-07       Impact factor: 1.310

2.  Lactobacillus plantarum 299v inhibits Escherichia coli-induced intestinal permeability.

Authors:  Peter Mangell; Pernilla Nejdfors; Mei Wang; Siv Ahrné; Bjorn Weström; Henrik Thorlacius; Bengt Jeppsson
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

Review 3.  Intestinal permeability, leaky gut, and intestinal disorders.

Authors:  D Hollander
Journal:  Curr Gastroenterol Rep       Date:  1999-10

4.  Probiotics, Irritable Bowel Syndrome, and Inflammatory Bowel Disease.

Authors:  Martin H. Floch
Journal:  Curr Treat Options Gastroenterol       Date:  2003-08

Review 5.  Anti-inflammatory effects of nicotine in obesity and ulcerative colitis.

Authors:  Shaheen E Lakhan; Annette Kirchgessner
Journal:  J Transl Med       Date:  2011-08-02       Impact factor: 5.531

6.  Absence of epithelial immunoglobulin A transport, with increased mucosal leakiness, in polymeric immunoglobulin receptor/secretory component-deficient mice.

Authors:  F E Johansen; M Pekna; I N Norderhaug; B Haneberg; M A Hietala; P Krajci; C Betsholtz; P Brandtzaeg
Journal:  J Exp Med       Date:  1999-10-04       Impact factor: 14.307

7.  Heparan Sulfate Mimetics: A New Way to Optimize Therapeutic Effects of Hydrogel-Embedded Mesenchymal Stromal Cells in Colonic Radiation-Induced Damage.

Authors:  Lara Moussa; Christelle Demarquay; Gildas Réthoré; Mohamed Amine Benadjaoud; Fernando Siñeriz; Girish Pattapa; Jérôme Guicheux; Pierre Weiss; Denis Barritault; Noëlle Mathieu
Journal:  Sci Rep       Date:  2019-01-17       Impact factor: 4.379

8.  Altered Structural Expression and Enzymatic Activity Parameters in Quiescent Ulcerative Colitis: Are These Potential Normalization Criteria?

Authors:  Sebastian Kjærgaard; Morten M B Damm; Joan Chang; Lene B Riis; Hanne B Rasmussen; Rasmus Hytting-Andreasen; Susanne M Krug; Jörg-Dieter Schulzke; Niels Bindslev; Mark Berner Hansen
Journal:  Int J Mol Sci       Date:  2020-03-10       Impact factor: 5.923

9.  Effect of pharmacologically induced smooth muscle activation on permeability in murine colitis.

Authors:  Freek J Zijlstra; Marieke E van Meeteren; Ingrid M Garrelds; Maarten A C Meijssen
Journal:  Mediators Inflamm       Date:  2003-02       Impact factor: 4.711

10.  Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity.

Authors:  Sya N Ukena; Anurag Singh; Ulrike Dringenberg; Regina Engelhardt; Ursula Seidler; Wiebke Hansen; André Bleich; Dunja Bruder; Anke Franzke; Gerhard Rogler; Sebastian Suerbaum; Jan Buer; Florian Gunzer; Astrid M Westendorf
Journal:  PLoS One       Date:  2007-12-12       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.